These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36966223)

  • 41. DARPP-32 is required for MAPK/ERK signaling in thyroid cells.
    Chocarro-Calvo A; Zaballos MA; Santisteban P; García-Jiménez C
    Mol Endocrinol; 2012 Mar; 26(3):471-80. PubMed ID: 22301787
    [TBL] [Abstract][Full Text] [Related]  

  • 42. SGK1 phosphorylation of IkappaB Kinase alpha and p300 Up-regulates NF-kappaB activity and increases N-Methyl-D-aspartate receptor NR2A and NR2B expression.
    Tai DJ; Su CC; Ma YL; Lee EH
    J Biol Chem; 2009 Feb; 284(7):4073-89. PubMed ID: 19088076
    [TBL] [Abstract][Full Text] [Related]  

  • 43. IKKalpha regulates mitogenic signaling through transcriptional induction of cyclin D1 via Tcf.
    Albanese C; Wu K; D'Amico M; Jarrett C; Joyce D; Hughes J; Hulit J; Sakamaki T; Fu M; Ben-Ze'ev A; Bromberg JF; Lamberti C; Verma U; Gaynor RB; Byers SW; Pestell RG
    Mol Biol Cell; 2003 Feb; 14(2):585-99. PubMed ID: 12589056
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthetic peptide analogs of DARPP-32 (Mr 32,000 dopamine- and cAMP-regulated phosphoprotein), an inhibitor of protein phosphatase-1. Phosphorylation, dephosphorylation, and inhibitory activity.
    Hemmings HC; Nairn AC; Elliott JI; Greengard P
    J Biol Chem; 1990 Nov; 265(33):20369-76. PubMed ID: 2173704
    [TBL] [Abstract][Full Text] [Related]  

  • 45. PP1, PKA and DARPP-32 in breast cancer: A retrospective assessment of protein and mRNA expression.
    Saidy B; Kotecha S; Butler A; Rakha EA; Ellis IO; Green AR; Martin SG; Storr SJ
    J Cell Mol Med; 2021 Jun; 25(11):5015-5024. PubMed ID: 33991172
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Protein Kinase-Mediated Decision Between the Life and Death.
    Engin A
    Adv Exp Med Biol; 2021; 1275():1-33. PubMed ID: 33539010
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regulation of CD44E by DARPP-32-dependent activation of SRp20 splicing factor in gastric tumorigenesis.
    Zhu S; Chen Z; Katsha A; Hong J; Belkhiri A; El-Rifai W
    Oncogene; 2016 Apr; 35(14):1847-56. PubMed ID: 26119931
    [TBL] [Abstract][Full Text] [Related]  

  • 48. IKKalpha and IKKbeta each function to regulate NF-kappaB activation in the TNF-induced/canonical pathway.
    Adli M; Merkhofer E; Cogswell P; Baldwin AS
    PLoS One; 2010 Feb; 5(2):e9428. PubMed ID: 20195534
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Attribution of NF-κB Activity to CHUK/IKKα-Involved Carcinogenesis.
    Li X; Hu Y
    Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33808757
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Src Promotes Metastasis of Human Non-Small Cell Lung Cancer Cells through Fn14-Mediated NF-κB Signaling.
    Wang W; Liu F; Wang C; Wang C; Tang Y; Jiang Z
    Med Sci Monit; 2018 Mar; 24():1282-1294. PubMed ID: 29500337
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activation of the heterodimeric IkappaB kinase alpha (IKKalpha)-IKKbeta complex is directional: IKKalpha regulates IKKbeta under both basal and stimulated conditions.
    O'Mahony A; Lin X; Geleziunas R; Greene WC
    Mol Cell Biol; 2000 Feb; 20(4):1170-8. PubMed ID: 10648602
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulation and function of IKK and IKK-related kinases.
    Häcker H; Karin M
    Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Compensatory IKKalpha activation of classical NF-kappaB signaling during IKKbeta inhibition identified by an RNA interference sensitization screen.
    Lam LT; Davis RE; Ngo VN; Lenz G; Wright G; Xu W; Zhao H; Yu X; Dang L; Staudt LM
    Proc Natl Acad Sci U S A; 2008 Dec; 105(52):20798-803. PubMed ID: 19104039
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Darpp-32 and its truncated variant t-Darpp have antagonistic effects on breast cancer cell growth and herceptin resistance.
    Gu L; Waliany S; Kane SE
    PLoS One; 2009 Jul; 4(7):e6220. PubMed ID: 19593441
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regulation of DARPP-32 dephosphorylation at PKA- and Cdk5-sites by NMDA and AMPA receptors: distinct roles of calcineurin and protein phosphatase-2A.
    Nishi A; Bibb JA; Matsuyama S; Hamada M; Higashi H; Nairn AC; Greengard P
    J Neurochem; 2002 May; 81(4):832-41. PubMed ID: 12065642
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Protein phosphatase 1 regulation by inhibitors and targeting subunits.
    Watanabe T; Huang HB; Horiuchi A; da Cruze Silva EF; Hsieh-Wilson L; Allen PB; Shenolikar S; Greengard P; Nairn AC
    Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3080-5. PubMed ID: 11248035
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nuclear factor-inducing kinase plays a crucial role in osteopontin-induced MAPK/IkappaBalpha kinase-dependent nuclear factor kappaB-mediated promatrix metalloproteinase-9 activation.
    Rangaswami H; Bulbule A; Kundu GC
    J Biol Chem; 2004 Sep; 279(37):38921-35. PubMed ID: 15247285
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Functional isoforms of IkappaB kinase alpha (IKKalpha) lacking leucine zipper and helix-loop-helix domains reveal that IKKalpha and IKKbeta have different activation requirements.
    McKenzie FR; Connelly MA; Balzarano D; Müller JR; Geleziunas R; Marcu KB
    Mol Cell Biol; 2000 Apr; 20(8):2635-49. PubMed ID: 10733566
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner.
    Krysan K; Reckamp KL; Dalwadi H; Sharma S; Rozengurt E; Dohadwala M; Dubinett SM
    Cancer Res; 2005 Jul; 65(14):6275-81. PubMed ID: 16024629
    [TBL] [Abstract][Full Text] [Related]  

  • 60. miR-19b enhances proliferation and apoptosis resistance via the EGFR signaling pathway by targeting PP2A and BIM in non-small cell lung cancer.
    Baumgartner U; Berger F; Hashemi Gheinani A; Burgener SS; Monastyrskaya K; Vassella E
    Mol Cancer; 2018 Feb; 17(1):44. PubMed ID: 29455644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.